CN106579387A - Arabinose-enzyme composition and preparation method thereof - Google Patents
Arabinose-enzyme composition and preparation method thereof Download PDFInfo
- Publication number
- CN106579387A CN106579387A CN201611167731.0A CN201611167731A CN106579387A CN 106579387 A CN106579387 A CN 106579387A CN 201611167731 A CN201611167731 A CN 201611167731A CN 106579387 A CN106579387 A CN 106579387A
- Authority
- CN
- China
- Prior art keywords
- arabinose
- ferment
- enzyme composition
- enzyme
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims description 12
- 102000004190 Enzymes Human genes 0.000 claims abstract description 69
- 108090000790 Enzymes Proteins 0.000 claims abstract description 69
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 67
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 23
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 21
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 20
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 16
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000811 xylitol Substances 0.000 claims abstract description 16
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 16
- 235000010447 xylitol Nutrition 0.000 claims abstract description 16
- 229960002675 xylitol Drugs 0.000 claims abstract description 16
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 11
- 235000013311 vegetables Nutrition 0.000 claims abstract description 9
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 46
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 22
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 20
- 239000001814 pectin Substances 0.000 claims description 19
- 229920001277 pectin Polymers 0.000 claims description 19
- 235000010987 pectin Nutrition 0.000 claims description 16
- 235000000346 sugar Nutrition 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 10
- 239000000835 fiber Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- -1 Fructose oligosaccharides Chemical class 0.000 claims description 6
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 6
- 241001428166 Eucheuma Species 0.000 claims description 5
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 244000269722 Thea sinensis Species 0.000 claims description 5
- 235000009569 green tea Nutrition 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 5
- 235000005911 diet Nutrition 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 101100381997 Danio rerio tbc1d32 gene Proteins 0.000 claims description 3
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- 101100381999 Mus musculus Tbc1d32 gene Proteins 0.000 claims description 3
- 229920001100 Polydextrose Polymers 0.000 claims description 3
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 235000021014 blueberries Nutrition 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 230000000378 dietary effect Effects 0.000 claims description 3
- 235000004213 low-fat Nutrition 0.000 claims description 3
- 239000001259 polydextrose Substances 0.000 claims description 3
- 235000013856 polydextrose Nutrition 0.000 claims description 3
- 229940035035 polydextrose Drugs 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 238000010792 warming Methods 0.000 claims description 2
- PYMYPHUHKUWMLA-VAYJURFESA-N aldehydo-L-arabinose Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VAYJURFESA-N 0.000 claims 2
- 241000206572 Rhodophyta Species 0.000 claims 1
- 240000000249 Morus alba Species 0.000 abstract description 17
- 235000008708 Morus alba Nutrition 0.000 abstract description 17
- 239000000463 material Substances 0.000 abstract description 5
- 229940088598 enzyme Drugs 0.000 description 57
- 230000000968 intestinal effect Effects 0.000 description 34
- 241000894006 Bacteria Species 0.000 description 32
- 238000000855 fermentation Methods 0.000 description 30
- 230000004151 fermentation Effects 0.000 description 30
- 210000004369 blood Anatomy 0.000 description 28
- 239000008280 blood Substances 0.000 description 28
- 230000000694 effects Effects 0.000 description 26
- 241000196324 Embryophyta Species 0.000 description 19
- 239000006041 probiotic Substances 0.000 description 16
- 235000018291 probiotics Nutrition 0.000 description 16
- 230000000529 probiotic effect Effects 0.000 description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 235000013325 dietary fiber Nutrition 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 239000008103 glucose Substances 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 230000036541 health Effects 0.000 description 13
- 230000009286 beneficial effect Effects 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 229960003487 xylose Drugs 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 235000013406 prebiotics Nutrition 0.000 description 9
- 229910052711 selenium Inorganic materials 0.000 description 9
- 239000011669 selenium Substances 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000035764 nutrition Effects 0.000 description 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 240000002791 Brassica napus Species 0.000 description 4
- 235000011293 Brassica napus Nutrition 0.000 description 4
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 208000002925 dental caries Diseases 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000035800 maturation Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 238000005842 biochemical reaction Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000001473 noxious effect Effects 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000004380 Cholic acid Substances 0.000 description 2
- 241001478240 Coccus Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241001505096 Rhamnus davurica Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 235000019416 cholic acid Nutrition 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 229960002471 cholic acid Drugs 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000004026 insulin derivative Substances 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 235000021092 sugar substitutes Nutrition 0.000 description 2
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 1
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 125000003599 L-arabinosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)CO1)* 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229920001991 Proanthocyanidin Polymers 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- 102000008114 Selenoproteins Human genes 0.000 description 1
- 108010074686 Selenoproteins Proteins 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003026 anti-oxygenic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000784 hepatotoxin Toxicity 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 229930010796 primary metabolite Natural products 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 150000003346 selenoethers Chemical class 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000015487 sulforaphane Nutrition 0.000 description 1
- 229960005559 sulforaphane Drugs 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000000112 undernutrition Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
An arabinose-enzyme composition is prepared from an enzyme that is prepared from vegetable or/and fruit material, wherein by weight L-arabinose accounts for 3-25 parts, xylitol accounts for 3-15 parts, and the enzyme accounts for 10-200 parts. By mulberry fruit of 20% and above, the enzyme is prepared, and 3-18 parts of oligosaccharide is added. In the arabinose-enzyme composition, the mass ratio of L-arabinose, xylitol and oligosaccharide is (5-10):(5-10):(8-15), and 1-5 parts of edible selenium powder is added.
Description
Technical field
The present invention relates to a kind of health food, more particularly to a kind of arabinose enzyme composition and preparation.
Background technology
CN105285383 proposes a kind of Arabic syrup and preparation method thereof, and syrup includes water and saccharic composition, water and sugar
Constituent mass volume ratio is 1～1.4：1；Saccharic composition is included by mass fraction：7～13 parts of L-arabinose, 5～9 parts of wood
Sugar and 2～5 parts of oligomeric xylose.Saccharic composition is included by mass fraction：10～12 parts of L-arabinose, 6～8 parts of xylose and
2.5～3.5 parts of oligomeric xylose.But the function of L-arabinose, xylose, oligomeric xylose, than relatively similar, three kinds of functional sugars are mutual
Effect is strong, especially the latter two functionally complete class it is same.It is beneficial to the quantity of flora in human body intestinal canal；Blood glucose can be controlled
Raise, suppress lipogenesis so that arabinose Fructus Mori compositionss are in sides such as prevention diabetes, constipation, three-hypers and eliminating toxin and beautifying the skin
Face has good effect, and long-term taking can allow intestinal beneficial flora to be bred at double.
The L-arabinose of arabinose especially main effect has been approved for new resources also known as Arabinose, pectose
Food.Although the half of L-arabinose sugariness only sucrose, the saccharase of sucrose is digested in energy selectivity negatively influencing small intestinal,
Suppress the absorption of sucrose so as to have obvious effect even directly to have a medical function at the control aspect such as blood glucose, the day of single 15g
Dosing is even used to treat the type-II diabetes at initial stage.Oligosaccharide is except the physicochemical properties with general utility functions oligosaccharide
Outward, most noticeable physiological property is that it can be obviously improved microbial population ratio in intestinal, and it is enteral bacillus bifiduss
The activation and proliferation factor, for probiotic bacteria carbon source is provided, and is a class non-digestible oligosaccharide, not by gastric acid and digestion enzymatic degradation, directly
Probiotic bacteria is preferably into big enteral to be utilized, while producing various organic acid, reduces gut pH, suppress harmful bacteria growing,
Probiotic bacteria is set to breed in a large number in intestinal.The generation of enteral corrupt substance can be reduced and be suppressed, suppresses the growth of noxious bacteria, be adjusted
Intestinal inner equilibrium；Trace elements iron, the absorption of calcium can be promoted and utilized, to prevent osteoporosis；Hepatotoxin, energy can be reduced
The organic acid of anticancer is generated in intestinal, there is significant preventing cancer function；And pure taste is fragrant and sweet good to eat, with the adipose fragrance of class
With tasty and refreshing soapy feeling.Typically have：Fructus Hordei Germinatus oligose glucose, fructose oligosaccharides, soybean oligo saccharide, polydextrose, gala
Sugared oligosaccharide, oligofructose, oligomeric xylose (β-Isosorbide-5-Nitrae glycosidic bond combination).
Xylitol is a kind of sweeting agent with nutritive value, and sugariness is suitable with sucrose, is sucrose and Fructus Vitis viniferae sugar substitute.
It is its a big feature that heat is low：2.4 calories per gram, than other little carbohydrates 40%.Welcome by diabetes patient very much.
It is the intermediate of human body carbohydate metabolism, and insulin is lacked in vivo to be affected in the case of carbohydrate metabolism, to promote without the need for insulin, xylose
Alcohol can also pass through cell membrane, be absorbed by tissue utilization, for cell with nutrition and energy, and blood glucose value will not be caused to raise, and eliminate
Diabetes patient's symptom more than three (polyphagia, polydipsia, polyuria), is the sugar substitutes of the trophism for being best suitable for patients with diabetes mellitus,
Sweeting agent, supplementary and the auxiliary therapeutical agent that diabetes patient can be is used.Xylitol can also improve liver function.It can promote
Liver glycogen synthesizes, and blood glucose will not rise, and having to hepatopath improves liver function and lipotropic effect.Xylitol is also preventing decayed tooth
The best sweeting agent of tooth, it is not produced cariogenic bacterial fermentation in oral cavity and is utilized, and suppresses the generation of streptococcus growth and acid；Energy
Promote salivation, slow down pH value decline, reduce the acid etching of tooth, prevent dental caries and reduce the generation of dental plaque, can consolidate
Tooth.Xylitol can reduce dental caries this characteristics, in high-risk rate crowd (dental caries incidence rate height, Undernutrition, oral hygiene
Level is low) and low risk crowd (being taken care of one's teeth using current all of cleaning of teeth measure, tooth cavity generation rate is low) in be
It is suitable for.Xylitol also has weight losing function.Energy is provided for human body, synthesizes glycogen, the protein in reduction fat and hepatic tissue
Consume, liver is protected and is repaired, eliminate the generation that ketoboidies is harmful in human body, will not be worry of getting fat because edible.Wood
Sugar alcohol biological stability is good, good hygroscopicity.
As the mankind are to health care and the requirement of auxiliary treatment diabetes, need to prepare one kind with health care, convenient food
Arabinose compositionss.
Ferment refers to the biological effect active substance that bacterium is participated in from fermentation.Bacterium source ferment favourable to human body in prebiotic ferment
Element includes：What active probiotic (probiotics) body, probiotic bacteria were produced is respectively enzyme (enzyme), prebiotic granulose
(Lactobacilluspolysaccharide), lactein (Lactobacteriosin) four is most of.Active probiotic sheet
Body, including lactic acid bacteria and Bei La yeast, are that national governments and linked groups of the United Nations allow the safe bacterial strain present in food.
Have been widely used for various therapies.Generally comprise in prebiotic ferment：Lactobacillus acidophilus, Fructus rhamni (Rhamnus davurica Pall.) saccharobacillus, the bright coccus of a beading,
Bifidobacterium adolescentiss, Lactobacillus plantarum, Bifidobacterium bifidum, Lu Shi lactic acid bacterias, being even more in reinforcing ferment includes 150 kinds of high activities
Probiotic bacteria.The enzyme that probiotic bacteria is produced in raw ferment is exactly in fact Louis. the ferment (ferment) of Pasteur original definition.Including：
Sour enzyme system is produced, is synthesized polysaccharide enzyme system, the enzyme system of decomposing nitrosamine, is reduced cholesterol enzyme system, control endotoxin enzyme system, reduces fat
Enzyme system, synthetic vitamin enzyme system, decomposition cholic acid enzyme system, oxalic acid deshydroxy enzyme, superoxide dismutase.Prebiotic granulose in ferment
(Lactobacillus polysaccharide), lactein (Lactobacteriosin) also serve as safe effect thing
Matter, is being widely used in the fields such as treatment of cancer, food antiseptic.All prebiotic ferment all contain bacterium source ferment, therefore they
Constitute the general utility functionss of prebiotic ferment.
The plant source ferment contained in prebiotic ferment, including：Enzyme (enzyme), phytochemistry element (Phytochemicals) two
Big class.Enzyme in the ferment of plant source includes：Superoxide dismutase, Fructus Ananadis comosi protease, papain, Vc digestive enzyme, Fructus Fici disappear
Change phytochemistry element point primary metabolite and secondary that enzyme, chitinase, oxalic acid deoxygenase, myrosin ... are planted in the ferment of source
The class of metabolite two.According to chemical composition then include：Polyphenol, Saponin, polysaccharide, terpene, ketone, alkene, glycosides, phytosterol, phytohormone etc..In
Magnificent national rarity, the traditional Chinese medical science and dietetic therapy, its core content is exactly rationally to be got rid of illness health preserving using these phytochemistry elements.
The content of the invention
It is an object of the present invention to provide a kind of arabinose enzyme composition and preparation method.Compositionss optimize intestinal with
Ecology, be provided in particular in the fermented product such as Fructus Mori based on L-arabinose, xylitol and oligosaccharide in intestinal with microbial bacteria
The reciprocal effect fallen with cyton, therefore, it is possible to have the healthy effect for more preferably adjusting human body.
The technical scheme is that, arabinose enzyme composition, including ferment, ferment is that vegetable or fruit are former
Ferment prepared by material, quality formula is as follows：The L-arabinose of 3-25 parts, 3-15 part xylitol, ferment 10-200 parts.
With the ferment made above of Fructus Mori mass content 20%, and add 3-18 part oligosaccharide.
Semisolid can be prepared in compositionss, it is also possible to add water, the quality of water is the 0.2-3 of all substances quality
Times.
L-arabinose of the purity that arabinose is extracted using biofermentation up to more than 99.0%；L-arabinose：Wood
Sugar alcohol component mass ratio is 1-1.4：1-4；Oligosaccharide includes：Fructose oligosaccharides, polydextrose, GOS, oligomeric wood
Sugar, oligomeric isomaltose, oligomeric lactose, soybean oligo saccharide.
Ferment 30-60 parts, and add edible fiber 10-80 parts.Edible fiber selects Herba bromi japonici (skin), Testa Fagopyri Esculenti, Rhizoma amorphophalli, sea
The algae such as band, Eucheuma muricatum (Gmel.) Web.Van Bos., equator red algae Eucheuma muricatum (Gmel.) Web.Van Bos., including (Equations of The Second Kind) water soluble dietary fiber：Low fat pectin, high fat pectin,
Apple pectin, pomelo-pectin, blue berry pectin, Fructus Ananadis comosi pectin, agar powder, carboxymethyl cellulose water soluble dietary fiber.
The quality parts ratio of L-arabinose, xylitol and oligomeric xylose is 5-10 in arabinose compositionss:5-10:8-
15。
Described arabinose enzyme composition, then add edible selenium powder, addition quality is 1-5 parts.
Ferment raw material using 20-50% quality Fructus Mori, and using Fructus Citri Limoniae, Fructus Lycopersici esculenti, green tea, then add Lactobacillus and
Shellfish draws yeast addition 1-2%, 25-32 DEG C of 7-25 days Production Time.
Ferment adds fresh Fructus Chaenomeliss and/or white turnip, or even the blue certain kind of berries.
The preparation method of described arabinose compositionss, adds xylitol, L-arabinose and oligosaccharide in water, heat up
To 80 DEG C of pasteurizing temperatures, add after cooling and 30-45min is incubated under ferment, stirring condition, that is, arabinose compositionss are obtained
Bottling.Addition 5-18 part oligosaccharide.Another addition water, the quality of water is 0.2-10 times of above-mentioned all substances quality.
Product of the purity that arabinose is extracted using biofermentation up to more than 99.0%.L-arabinose：Xylitol group
Mass ratio is divided to be 1～1.4：1～4；
Ferment in particular by Fructus Mori 20-100% quality, other adopt Fructus Citri Limoniae, Fructus Lycopersici esculenti, green tea, then add Lactic acid bacteria drink
Sour bacterium and Bei La yeast addition 1-2%, 25-32 DEG C of 7-25 days Production Time.Raw material can also add fresh Fructus Chaenomeliss, white turnip in ferment.
The preparation method of arabinose compositionss, ferment is prepared and completed；Xylitol, L-arabinose and oligomeric are added in water
Sugar, edible fiber, are warming up to 80 DEG C of pasteurizing temperatures, add after cooling and 30-45min is incubated under ferment, stirring condition, that is, make
Obtain the bottling of arabinose compositionss.
White turnip ferment can eliminate bodily waste rich in the amylase for decomposing harmful intestinal tract material, adjust intestinal group rings
Border, keeps enteral various bacteria balance.The ferment that Fructus Lycopersici esculenti produces gives protection against cancer, antitumaous effect is more higher than lycopene.It is green in green tea
Tea phenol is a kind of glutathione transferase, can increase the amount that Fructus Lycopersici esculenti produces ferment.Fructus Lycopersici esculenti ferment is to carcinoma of prostate and some digestion
The preventive effect of road cancer it is further preferred that.7-25 days or longer Production Time.
Active lactobacillus and Bei La yeast, especially shellfish draw yeast production yeast selenium, add in yeast culture medium suitable
The nothing of amount typically eats selenium powder yeast selenium, and organic selenium is produced to the accumulation ability of selenium using yeast, yeast is then peeled off, by nothing
Breaking cellular wall is produced after machine selenium is removed.The existence form of selenium is more complicated in the constituent yeast selenium of yeast selenium, including seleno egg ammonia
Acid, seleno Guang aminoacid, CH3SeH, selenoprotein and other selenides.Selenomethionine is also a kind of single selenium source.System
After the completion of standby day oral dose deal addition L-arabinose.
Take：Every morning is drunk after 200 milliliters of warm waters on an empty stomach, drinks the ferment combination of 20-50 milliliters (or more) Arab
Thing.The symptom for occurring similar " borborygmus/diarrhoea " during taking is that the intestines and stomach normally reacts.Suitable population：Malaise, Jing often feel
Emit, drowsy, stomach QI-insufficiency, constipation, it is fat, like drinking, long-term smoking, depression person, three-hypers, have cancer family history etc..
Fermentable ferment is that, with raw materials such as one or more vegetable or fruit, what Jing multiple beneficials bacterium was fermented and produced gives birth to rich in dimension
The functional microbial fermented food of the nutritional labelings such as element, enzyme, mineral and secondary metabolite.Enzyme microb have delay
The plurality of health care functions such as aging, anti-inflammation, purification blood, enhancing human body immunity ability and detoxicating and fighting cancer.Fermentation is mainly profit
With polysaccharide in the presence of yeast, ethanol, carbon dioxide, water and aromatic substance are decomposed into, so as to prepared flavour is sour-sweet, mouthfeel
The mulberry enzyme of sweet-smelling.The antioxygenic property of ferment is fermented essentially from sweat, Fructus Mori in the presence of microorganism,
Organic acid concentration increase in fermentation liquid makes the pH value of fermentation liquid 4 or so, and sour environment causes protein to be hydrolyzed to aminoacid.With
This simultaneously, yeast will vegetable fruit expect in enrich and complicated macromole aldehydes matter change into small molecule, total phenol content liter
Height, aldehydes matter is easy to provide a hydrion and stablize by resonance hybrid, makes mulberry enzyme DPPH free radical scavenging
Ability is significantly improved.In addition, the polyhydroxy on the A rings and B rings of chromocor compound molecule replaces and the 3- hydroxyls of free radical replace
Base can strengthen the Scavenging activity of the superoxide radical of ferment.Meanwhile, mulberry enzyme antioxidant content during the fermentation increases
Plus, its reducing power is significantly enhanced.
Enzyme microb is that fermentation of the active probiotic body to vegetable and fruit is obtained, and active probiotic mainly includes lactic acid
Bacterium and Bei La yeast, are that national governments and linked groups of the United Nations allow the safe bacterial strain present in food.Extensively used
In various therapies.Also include in prebiotic ferment：Lactobacillus acidophilus, Fructus rhamni (Rhamnus davurica Pall.) saccharobacillus, the bright coccus of a beading, youth bifid bar
Bacterium, Lactobacillus plantarum, Bifidobacterium bifidum, Lu Shi lactic acid bacterias, being even more in reinforcing ferment includes that more than 100 kinds of high activity is prebiotic
Bacterium colony.Ferment not only make use of the plant source ferment contained in veterinary antibiotics, and carry out attenuation synergistic to edible composition.Cause
This has very magical biological effect.Specifically this kind of plant source ferment has：Sulforaphane, resveratrol, ginsenoside, spirit
Sesame polysaccharide, anthocyanidin, limonin, bitter melon polysaccharide, gingerol, isoflavone, hydroxymalonic acid.
The preparation method of the composite plant ferment containing profitable probliotics, has selected the various fruits vegetable, medicine food dual purpose plant to be
Fermentation substrate, and using various probiotic bacteria/yeast as fermentation inoculum, using multicycle discontinuous fed-batch fermentation, the multistage depths of Jing
After layer fermentation, the composite plant ferment containing profitable probliotics is prepared.The species of the enzyme that prepared composite plant ferment contains
Many, activity is high, and good stability is affected by environment little.Using this method different time sections using the different substrates of different strain fermentation,
Make the different extracts active ingredients contained by all kinds of fermentation substrates more complete, whole system fermentation is more fully coordinated.Ferment
Element constitutes total performance of human life phenomenon in catalysis in vivo thousands of kinds of biochemical reactions.Machine can comprehensively be controlled and optimized to ferment
Internal milieu so as to keep dynamic equilibrium, that is, the equilibrium between yin and yang state described in the traditional Chinese medical science, is for healthy state.Ferment is in room temperature
In oxidation reaction produced by energy, and the storage and utilization of the energy, showing as ferment can enhance metabolism, and adjust
Section secretion, improves digestive function, and metabolic waste and toxin are eliminated in time, promotes the raw bacteria growing that overflows in intestinal, and keeps intestinal
The good intestinal environment of bacterial micro-ecological balance.Ferment carries out incessantly from many aspects internal efforts at environmental protection, makes human body dirty
Internal organs function keeps optimum state, improves body constitution, disease-prevention health health.Ferment can improve and maintain the normal bacterium phase of intestinal, have bowel relieving to arrange
Toxic action, it is possible to reduce enteral noxious substance is entered in blood, to keep blood pure.
Beneficial effect：Due to the absorption to sugar of the intestinal that has its source in of hyperglycemia, undue absorption glucose enters blood
Liquid causes insulin resistance or opposing, modal insulin resistance type and a kind of condition of illness contact for being referred to as metabolism syndrome
Together.Insulin resistance can develop into thoroughly type-II diabetes.Commonly post prandial hyperglycemia, in such case
Under, pancreas beta cell cannot produce enough insulins to keep normal glycemic levels.Beta cell nothing in the case of hyperglycemia
It is the feature changed from insulin resistance to type-II diabetes that power secretes more insulins.Emphasis is aimed at this by the present invention,
Optimization intestinal and ecology, comprehensive mechanism is more complicated, it should which Fructus Mori based on L-arabinose and oligosaccharide etc. are in intestinal
With microbe colony and the reciprocal effect of cyton, somatic cell is excited in beneficial agents, stimulates beneficial to produce, Mulberry on surface
Shen etc. and oligosaccharide, fiber can promote the wriggling of intestinal, and more deep effect is nutrition and strong intestinal cell, is had in absorption
Beneficial excitor substance (enzyme, peptide and small protein including producing), therefore, it is possible to adjust the immunity of human body, although on surface
Defecation is significantly improved, but the malicious and net blood of Eradicates more has influence on the health of human liver, so as to also remote-effects arrive kidney etc..Especially
Intestinal hinders absorption of the intestinal to multitudinous sugar because of L-arabinose, and the nutrition that glycogen becomes probiotic bacteria again is former, more have stimulated probiotic bacteria
Secretion beneficial products.
For from the origin of life, intestinal is the foundation of acquired constitution, and the intestinal of health is to absorb transporting food and various nutrition
The nutrition of product, the intestinal of the health immune organ that to be again function maximum with volume, the present invention based on the nutrition of intestinal, nourishing and
Health care can fully improve the transporting ability of intestinal.
Point out when dietary fiber is spoken of in health：" ... dietary fiber plays in vivo critical function, act as health
The role of bodyguard.Dietary fiber has a stimulation intestinal peristalsis promoting, increases the volume of intestinal contentses, reduce that feces stop in intestinal when
Between wait effect.Increase dietary fiber intake, can effectively preventing constipation, hemorrhoid prevent colon cancer, rectal cancer.Dietary fiber
The absorption of fat, cholesterol in intestinal can also be reduced, and promotes cholesterol and cholic acid to discharge from feces, thus have blood fat reducing,
The effect of cholesterol reducing.Additionally, the pectin in dietary fiber can extend the time of staying of the food in gastric, the suction of delay glucose
Speed is received, and reduces too high blood glucose, improve the symptom of diabetes.Increase the intake of dietary fiber, it is also fat with mitigating,
Breast Cancer Prevention ... waits effect ".It may be seen that the significance of diet fiber health-care effect.Correspondence China fitness-for-all shows
Shape and demand, can fully prove, dietary fiber has the huge social value for expediting the emergence of contemporary fitness-for-all.Ground according to analysis
Study carefully, if whole people's dietary fiber is in dietetic nutrition structure, keep the target of enough intakes, along with " three-hypers food " (high sugar,
Higher fatty acid, high protein) balance control and increase moderate exercise, then the sickness rate of China's nutrient imbalance metabolic disease can be
80% is at least reduced on the basis of existing.Especially Fructus Mori material further enhances immunologic function in intestinal, and resisting fatigue resists lean
Blood；The present invention is by a certain percentage added to the water the Fructus Mori of L-arabinose and oligosaccharide, makes functional sugar and Fructus Mori nutrient substance
Interact.Bacterium life group's growing environment in human body intestinal canal is lifted, the quantity of probiotic bacteria increases, Fructus Mori itself are again bacterium life all living creatures's length
Good medium, the back suction for adding L-arabinose receives the effect of sugared part, therefore, it can control people's blood glucose rise so that I
The sugared Fructus Mori compositionss of uncle in prevention diabetes, take a few days and intestinal beneficial flora can be allowed to breed at double, solves the problems, such as constipation, grow
Phase takes can substantially improve three high targets.
Formula according to embodiments of the present invention, body weight is close, the people of patient 8 with type Ⅱdiabetes mellitus without other medical histories
(blood glucose when before the meal in standard 50% or so, if do not taken hypoglycemic medicine), takes taken by the amount Consecutive Days of embodiment 1,2 after the meal
10 days, change of blood sugar was that, per reducing by more than 30% per capita, two blood glucose are completely normal.(blood glucose is before the meal in mark for the people of matched group two
When accurate 50% or so, if do not taken hypoglycemic medicine) unused this example 1,2, cause blood glucose to raise suddenly after the meal, deviate normal range.
The patient of type Ⅱdiabetes mellitus takes the consumption per day compositionss of embodiment 1,2 to the control effect of blood glucose more preferably.
Mice spleen lymphocytes proliferation ability of the present invention to ConA inductions, test sets the compositionss i.e. day of embodiment 1,2
Two dosage groups of consumption, negative control group is distilled water, using mtt assay, is as a result shown, high dose group can significantly improve mice
Spleen lymphocyte proliferation ability, surveys pouring and turns OD differences apparently higher than negative control group (P ＜ 0.05).And low dose group and control
Group is to spleen lymphocyte proliferation DeGrain (P ＞ 0.05).
The present invention can greatly enhance the antiinflammatory action of body itself using ferment, because ferment can make first cell
Compensation is strengthened, and especially gives inflammation part damaged cell power-assisted, greatly increases cell function excellent activity at this, so as to
Various compensations are conducive to give full play to antiinflammatory action.Phytic acid in plant is changed into into functional lactate and acetic acid, insoluble fibre
Dimension is changed into water soluble dietary fiber etc., affects more preferable to the positive of intestinal, and the product of preparation can be with various biologies in human activin
Enzyme, adjusts human metabolism function comprehensively.
Specific embodiment
The ferment of the present invention is made up of following methods, the probiotic bacteria 0.1-0.3 parts such as vegetable and fruit 25-60 part yeast,
0.2 part of Sal, water 35-100 parts the Fructus Mori of above-mentioned weight portion are accounted for 20-50% quality (especially more than 60% use Fructus Mori,
100% Fructus Mori can be adopted) raw material carries out first time fermentation, fermentation time 5 days, and fermentation room temperature is 20-28 DEG C, obtains one
Not good liquor and residue；Fructus Mori value is high, therefore the Dou Fructus Mori residues 20-32 parts that add water carry out second fermentation, and fermentation time 4 days is sent out
Ferment room temperature is 20-28 DEG C, and the mixing of the not good liquor of mulberry enzyme two is proceeded into maturation of fermenting, and fermentation maturation at least 70 days is obtained
Mulberry enzyme stock solution.
It is also conventional method that ferment adopts various vegetables together with fruit for raw material, and conventional also uses Herba Apii graveolentis, Fructus Citri Limoniae, kind
Eggplant, green tea, the fresh Fructus Chaenomeliss of addition, white turnip, Fructus Mali pumilae, pears etc., then the micro- life for adding Lactobacillus and Bei La yeast (main component)
Thing adds 1-2%, 25-35 DEG C of 7-25 days Production Time.Temperature is 20-25 DEG C of 25-45 days Production Time.
Concrete sweat is as follows：(1) it is saccharomycetic to activate with amplification culture aseptically, picking yeast seeds
On beef extract-peptone solid medium, after 35 DEG C of constant temperature culture 48h, stronger yeast of activity etc. is selected to mix bacterium in liquid
It is enlarged in culture medium and cultivates and carry out secondary spreading cultivation.
(2) cleaning of raw material takes out Fructus Mori in water after rinsed clean.
(3) fill basket and drain Fructus Mori fruit surface moisture in groove in special draining.
(4) crush barrelling carries out coarse pulverization by Fructus Mori, and granule is less than 2 millimeters.In the Fructus Mori for crushing add yeast,
Mel and Sal, mix, and are fitted in bucket after mineral water.Polypropylence Sheet is covered on the top of bucket, then is tightened with rubber case, and covered
Bung.
(5) fermentation of Fructus Mori and natural separation：Fermenter is put to the indoor fermentation of fermentation 5 days, the initial stage for carrying out Fructus Mori is sent out
Ferment, indoor temperature is controlled at 20-28 DEG C.
(6) shunting of the shunting one time fermentation liquid of mulberry enzyme：By menophania the fermenter that ferments transport to diffluence room, remove
Drop cloth, the cover plate for changing hole is covered on bung, bung is downwardly inclined on the splitter box for being placed in hole, above the hole of splitter box
Filter cloth is placed, mulberry enzyme liquid trickles naturally, realize being separated by filtration for mulberry enzyme liquid and residue, obtain mulberry enzyme once
Liquid.By the not good liquor of mulberry enzyme one being filtrated to get by pipeline, it is input in the tank body of fermentation ripening chamber with liquid-feeding pump；Two not good liquors
Shunting：Residue merging after one not good liquor is shunted is poured in bucket, adds mineral water to continue to be put into above-mentioned fermentation interior continuation
Fermentation, the time is 4 days, obtains the not good liquor of mulberry enzyme two.Two not good liquors and residue are separated by filtration.
(7) 36 DEG C of constant temperature of indoor maintenance of fermentation ripening chamber, by the liquid temperature that mulberry enzyme shunts liquid 38-40 DEG C is maintained,
Fermentation maturation at least 70 days, obtains mulberry enzyme stock solution.Mulberry enzyme stock solution fragrance pure taste, sugar≤6 g/l, total acid 12
G/l～17 g/l.The mulberry enzyme that the present invention is obtained remains to greatest extent the activity and function of effective ingredient, can be with
Unnecessary free radical, antioxidation in neutralization human body, slow down aging, alleviation eye strain, promotion cardiovascular health, reach beauty and support
The effect of face, building body, be a kind of good health product.
The present invention provides a kind of preparation method of plant enzyme, carry out plant enzyme natural extraction contain plant effectively into
The liquid for dividing, in maturation by fermentation, obtains liquid plant enzyme stock solution；The plant enzyme stock solution for obtaining contains multienzyme ferment
Element, proteolytic enzyme, lipase, amylolysis ferment, and containing proanthocyanidin, various natural complex, ore deposit
Material, aminoacid and trace element etc..With the plant enzyme stock solution for obtaining, plant enzyme liquid oral liquid, plant enzyme are made
Pressed powder or plant enzyme capsule.Preparation method of the present invention simulates the natural formation condition of ferment, and scientific in principle, equipment is simple
Large-scale production is suitable to, the plant enzyme pure natural feature for obtaining.Can be widely applied to health product or make up and cosmetics.
Edible fiber selects algae, the equator red algae Eucheuma muricatum (Gmel.) Web.Van Bos. such as Herba bromi japonici (skin), Testa Fagopyri Esculenti, Rhizoma amorphophalli, Thallus Laminariae (Thallus Eckloniae), Eucheuma muricatum (Gmel.) Web.Van Bos., bag
Include Equations of The Second Kind water soluble dietary fiber：Low fat pectin, high fat pectin, apple pectin, pomelo-pectin, blue berry pectin, Fructus Ananadis comosi pectin,
Agar powder, carboxymethyl cellulose water soluble dietary fiber.
Arabinose enzyme composition has very strong decomposition.All biochemical reactions in human body, nearly all will be
Carry out under the catalytic action of arabinose enzyme composition, while impossible chemical reaction originally can be driven, and can
Do not transnatured with accelerating its chemolysis effect.Arabinose enzyme composition can cause human body cell for each simultaneously
The catabolic process for planting the vascular aggregates things such as metabolic waste, lipid peroxide and thrombosis greatly speeds up, useless in vivo so as to accelerate
The discharge of thing, toxin, the various toxin for eliminating internal long term accumulation and the foreign body for hindering blood normal circulation, are kept for human body generation
Thank to the unimpeded of normal and various circulations.
Embodiment 1-19 (mass unit:g)
In blood of human body contain hundreds of ferment, these ferment can be substantially strengthen blood in various cells activity and
Function, while removing waste and toxin in blood, purifies blood.Additionally, ferment is during waste in decomposition blood, can
By noxious substances such as a large amount of ammonia of the entrance blood produced by people's vivo protein catabolic process element (Ammonia), to become low
Toxicity is excreted from urine, so that blood is purified, becomes salubrious, and keeps optimal pH-value, is given full play to
The important function that blood is stopped to people.
Arabinose enzyme composition has good resistant function for various antibacterials and virus, inherently a kind of natural
Antibiotics.Arabinose enzyme composition catalysis biochemical reaction process in can produce one kind be called " ablastins " it is special because
Son, the factor pair antibacterial, virus have inhibitory action, just as the aerosol bomb of cuttle fish rear release under attack, form a kind of
" biological barrier " be enough to resist external enemy, so as to reduce hazardness of the bacterial viruses to human body.Research display, arabinose ferment
Promotor composition also has inhibitory action to harmful microorganism, and arabinose enzyme composition is to escherichia coli, Pseudomonas aeruginosa, gold
The inhibitory action of Staphylococcus aureus and three kinds of acne pathogen is confirmed.
Above-described specific embodiment, has been carried out further to the purpose of the present invention, technical scheme and beneficial effect
Describe in detail, should be understood that the specific embodiment that the foregoing is only the present invention, be not intended to limit the present invention
Protection domain, all any modification, equivalent substitution and improvements within the spirit and principles in the present invention, done etc. all should include
Within protection scope of the present invention.
Claims (10)
1. arabinose enzyme composition, is characterized in that including ferment, and ferment is ferment prepared by vegetable or fruit raw material,
Quality formula is as follows：The L- arabinose of 3-25 parts, 3-15 part xylitol, ferment 10-200 parts.
2. arabinose enzyme composition according to claim 1, is characterized in that preparing ferment with more than 20% Fructus Mori quality
Element, and add 3-18 part oligosaccharide.
3. arabinose enzyme composition according to claim 2, is characterized in that adding water in compositionss, and the quality of water is
0.2-3 times of all substances quality.
4. arabinose enzyme composition according to claim 2, is characterized in that arabinose is extracted using biofermentation
L-arabinose of the purity up to more than 99.0%；L-arabinose：Xylitol constituent mass ratio is 1-1.4：1-4；Oligosaccharide
Including：Fructose oligosaccharides, polydextrose, GOS, oligomeric xylose, oligomeric isomaltose, oligomeric lactose, soy oligosaccharides
Sugar.
5. arabinose enzyme composition according to claim 1, is characterized in that ferment 30-60 parts；And add edible fine
Dimension 10-80 parts；Edible fiber selects Herba bromi japonici（Skin）, Testa Fagopyri Esculenti, Rhizoma amorphophalli, Thallus Laminariae (Thallus Eckloniae), Eucheuma muricatum (Gmel.) Web.Van Bos., equator red algae, aqueous soluble dietary is fine
Dimension：Low fat pectin, high fat pectin, apple pectin, pomelo-pectin, blue berry pectin, Fructus Ananadis comosi pectin, agar powder, carboxymethyl cellulose.
6. arabinose enzyme composition according to claim 1, it is characterized in that in arabinose compositionss L- I
The quality parts ratio of uncle's sugar, xylitol and oligomeric xylose is 5-10:5-10 :8-15.
7. the arabinose enzyme composition according to one of claim 1-6, is characterized in that adding edible selenium powder, add matter
Measure as 1-5 parts.
8. arabinose enzyme composition according to claim 7, is characterized in that quality of the ferment raw material using 20-50%
Fructus Mori, Fructus Citri Limoniae, Fructus Lycopersici esculenti, green tea, then add Lactobacillus and Bei La yeast addition 1-2%, 25-32 DEG C of Production Time 7-15
My god.
9. arabinose enzyme composition according to claim 7, is characterized in that adding fresh Fructus Chaenomeliss/or white in ferment raw material
Radix Raphani.
10. the preparation method of arabinose compositionss according to claim 7, is characterized in that prepared by ferment and completes；In water
Xylitol, L- arabinose and oligosaccharide, edible fiber are added, 80 DEG C of pasteurizing temperatures are warming up to, ferment is added after cooling
30-45min is incubated under element, stirring condition, that is, the bottling of arabinose compositionss is obtained.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611167731.0A CN106579387A (en) | 2016-12-16 | 2016-12-16 | Arabinose-enzyme composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611167731.0A CN106579387A (en) | 2016-12-16 | 2016-12-16 | Arabinose-enzyme composition and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106579387A true CN106579387A (en) | 2017-04-26 |
Family
ID=58600494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611167731.0A Pending CN106579387A (en) | 2016-12-16 | 2016-12-16 | Arabinose-enzyme composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106579387A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107898762A (en) * | 2017-11-21 | 2018-04-13 | 闽南师范大学 | A kind of shaddock ped cellulose tablet and preparation method thereof |
| CN108157780A (en) * | 2018-02-09 | 2018-06-15 | 叶小勇 | A kind of food for assisting control body weight and preparation method thereof |
| CN108813594A (en) * | 2018-07-02 | 2018-11-16 | 杭州相生相成科技有限公司 | A kind of Ma Qiguo ferment and its compounding method |
| CN109043259A (en) * | 2018-07-31 | 2018-12-21 | 天津市圭谷科技发展有限公司 | A kind of ferment L-arabinose stachyose composite beverage underflow |
| CN109170875A (en) * | 2018-08-27 | 2019-01-11 | 山东福田药业有限公司 | A kind of ferment 3D printing food material and preparation method thereof |
| CN109198335A (en) * | 2018-09-19 | 2019-01-15 | 杭州德能生物医药有限公司 | The formula of plant enzyme draft drink |
| CN109527545A (en) * | 2018-12-01 | 2019-03-29 | 山东先大健康产业股份有限公司 | The formula and preparation method of a kind of L-arabinose, ferment and Freeze-dry Powder of Probioctics |
| CN110037287A (en) * | 2019-04-26 | 2019-07-23 | 山东福田药业有限公司 | A kind of mulberry enzyme powder and preparation method thereof |
| CN113907233A (en) * | 2021-10-14 | 2022-01-11 | 厦门绿泗海生物科技有限公司 | Probiotic fruit juice and preparation process thereof |
| CN115153011A (en) * | 2022-07-04 | 2022-10-11 | 广州正明后生元科技有限公司 | A metabiotic composition for regulating gastrointestinal tract, and its preparation method |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1112603A (en) * | 1993-07-12 | 1995-11-29 | 圭马斯食品股份有限公司 | Food ingredients obtained by fermentation with S. boulardii and foods containing them |
| CN103462158A (en) * | 2013-09-09 | 2013-12-25 | 江苏恒顺醋业股份有限公司 | Mulberry enzyme beverage and preparation method thereof |
| CN105249452A (en) * | 2015-10-10 | 2016-01-20 | 山东龙力生物科技股份有限公司 | Fruit and vegetable enzyme powder with weight reducing function and preparation method thereof |
| CN105285283A (en) * | 2015-10-09 | 2016-02-03 | 北京甜思思电子商务有限公司 | Arab syrup and preparation method thereof |
-
2016
- 2016-12-16 CN CN201611167731.0A patent/CN106579387A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1112603A (en) * | 1993-07-12 | 1995-11-29 | 圭马斯食品股份有限公司 | Food ingredients obtained by fermentation with S. boulardii and foods containing them |
| CN103462158A (en) * | 2013-09-09 | 2013-12-25 | 江苏恒顺醋业股份有限公司 | Mulberry enzyme beverage and preparation method thereof |
| CN105285283A (en) * | 2015-10-09 | 2016-02-03 | 北京甜思思电子商务有限公司 | Arab syrup and preparation method thereof |
| CN105249452A (en) * | 2015-10-10 | 2016-01-20 | 山东龙力生物科技股份有限公司 | Fruit and vegetable enzyme powder with weight reducing function and preparation method thereof |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107898762A (en) * | 2017-11-21 | 2018-04-13 | 闽南师范大学 | A kind of shaddock ped cellulose tablet and preparation method thereof |
| CN107898762B (en) * | 2017-11-21 | 2020-06-09 | 闽南师范大学 | Shaddock peel cellulose tablet and preparation method thereof |
| CN108157780A (en) * | 2018-02-09 | 2018-06-15 | 叶小勇 | A kind of food for assisting control body weight and preparation method thereof |
| CN108813594A (en) * | 2018-07-02 | 2018-11-16 | 杭州相生相成科技有限公司 | A kind of Ma Qiguo ferment and its compounding method |
| CN109043259A (en) * | 2018-07-31 | 2018-12-21 | 天津市圭谷科技发展有限公司 | A kind of ferment L-arabinose stachyose composite beverage underflow |
| CN109170875A (en) * | 2018-08-27 | 2019-01-11 | 山东福田药业有限公司 | A kind of ferment 3D printing food material and preparation method thereof |
| CN109198335A (en) * | 2018-09-19 | 2019-01-15 | 杭州德能生物医药有限公司 | The formula of plant enzyme draft drink |
| CN109527545A (en) * | 2018-12-01 | 2019-03-29 | 山东先大健康产业股份有限公司 | The formula and preparation method of a kind of L-arabinose, ferment and Freeze-dry Powder of Probioctics |
| CN110037287A (en) * | 2019-04-26 | 2019-07-23 | 山东福田药业有限公司 | A kind of mulberry enzyme powder and preparation method thereof |
| CN110037287B (en) * | 2019-04-26 | 2022-06-10 | 山东福田药业有限公司 | Mulberry enzyme powder and preparation method thereof |
| CN113907233A (en) * | 2021-10-14 | 2022-01-11 | 厦门绿泗海生物科技有限公司 | Probiotic fruit juice and preparation process thereof |
| CN115153011A (en) * | 2022-07-04 | 2022-10-11 | 广州正明后生元科技有限公司 | A metabiotic composition for regulating gastrointestinal tract, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106579387A (en) | Arabinose-enzyme composition and preparation method thereof | |
| CN103027231B (en) | Compound probiotics fermented Chinese herbal medicine active health care liquid and preparation method thereof | |
| CN104872674A (en) | Medlar and red date enzyme and preparation method thereof | |
| CN105167072A (en) | Production method of functional Chinese wolfberry fruit enzyme and product thereof | |
| CN104643225A (en) | Liquorice vegetable drink for improving gastrointestinal function and enhancing immunity and preparation method of liquorice vegetable drink | |
| CN104982928B (en) | A kind of japanese yew fruit health care ferment and preparation method thereof | |
| CN101245307A (en) | Melon and fruit vinegar and manufacture method thereof | |
| CN104664512A (en) | Licorice plant drink capable of enhancing immunity as well as preparation method thereof | |
| CN103798890A (en) | Tea fungus apple vinegar and production method thereof | |
| CN103039927A (en) | Biologically fermented black purslane food and preparation method thereof | |
| CN104757670A (en) | Liquorice health-care plant beverage and preparation method thereof | |
| CN105707772A (en) | Blueberry composite powder capable of improving performance of intestinal tracts and preparation method of blueberry composite powder | |
| CN108283285A (en) | A kind of health-care physiotherapeutic food of diabetes | |
| CN106165780A (en) | A kind of broiler Chinese medicine composite probiotics feed additive and preparation method thereof | |
| CN105725123A (en) | Blueberry composite powder high in anthocyanin content and preparing method thereof | |
| CN107173656A (en) | A kind of Chinese medicine fruits and vegetables probiotics fermented beverage and preparation method thereof | |
| CN104605018A (en) | Functional fermented milk and preparation method thereof | |
| CN110547447A (en) | Royal jelly collagen fruit enzyme and preparation method thereof | |
| CN108740891A (en) | A kind of Preserved-fish capsicums and preparation method thereof | |
| CN104664513A (en) | Licorice plant beverage and preparation method thereof | |
| CN105661399A (en) | Blueberry composite powder and preparation method thereof | |
| CN103653107A (en) | Preparation method of probiotic fermented kiwi fruit juice | |
| CN105768102A (en) | Enzyme-containing blueberry composite powder and preparation method thereof | |
| CN105639645A (en) | Blueberry composite powder capable of reducing cholesterol and method for preparing blueberry composite powder | |
| CN110279050A (en) | A kind of pectase beverage of detoxicating intestine and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170426 |
|
| RJ01 | Rejection of invention patent application after publication |